Vanguard Group’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$66.5M Buy
2,248,211
+1,643
+0.1% +$48.6K ﹤0.01% 2004
2025
Q1
$67.1M Sell
2,246,568
-36,098
-2% -$1.08M ﹤0.01% 1964
2024
Q4
$65.4M Sell
2,282,666
-63,876
-3% -$1.83M ﹤0.01% 2046
2024
Q3
$90.7M Sell
2,346,542
-24,400
-1% -$943K ﹤0.01% 1918
2024
Q2
$76.3M Buy
2,370,942
+40,214
+2% +$1.29M ﹤0.01% 1963
2024
Q1
$90.5M Buy
2,330,728
+17,942
+0.8% +$697K ﹤0.01% 1915
2023
Q4
$71.2M Sell
2,312,786
-26,310
-1% -$810K ﹤0.01% 2032
2023
Q3
$52.3M Buy
2,339,096
+2,339
+0.1% +$52.3K ﹤0.01% 2118
2023
Q2
$50.2M Buy
2,336,757
+30,817
+1% +$662K ﹤0.01% 2184
2023
Q1
$55.3M Buy
2,305,940
+97,829
+4% +$2.35M ﹤0.01% 2129
2022
Q4
$51.2M Sell
2,208,111
-92,076
-4% -$2.14M ﹤0.01% 2176
2022
Q3
$36.8M Buy
2,300,187
+25,801
+1% +$413K ﹤0.01% 2327
2022
Q2
$40.3M Sell
2,274,386
-32,143
-1% -$570K ﹤0.01% 2295
2022
Q1
$47M Buy
2,306,529
+19,112
+0.8% +$389K ﹤0.01% 2338
2021
Q4
$42.7M Sell
2,287,417
-57,065
-2% -$1.07M ﹤0.01% 2443
2021
Q3
$46.3M Buy
2,344,482
+104,093
+5% +$2.05M ﹤0.01% 2408
2021
Q2
$53M Buy
2,240,389
+54,009
+2% +$1.28M ﹤0.01% 2341
2021
Q1
$51.8M Buy
2,186,380
+455,528
+26% +$10.8M ﹤0.01% 2296
2020
Q4
$34.7M Buy
1,730,852
+58,222
+3% +$1.17M ﹤0.01% 2381
2020
Q3
$34.8M Sell
1,672,630
-25,603
-2% -$533K ﹤0.01% 2200
2020
Q2
$29.7M Sell
1,698,233
-1,427
-0.1% -$25K ﹤0.01% 2242
2020
Q1
$27.8M Buy
1,699,660
+19,006
+1% +$310K ﹤0.01% 2140
2019
Q4
$34.6M Buy
1,680,654
+116,944
+7% +$2.41M ﹤0.01% 2281
2019
Q3
$18M Sell
1,563,710
-7,764
-0.5% -$89.1K ﹤0.01% 2539
2019
Q2
$20.7M Buy
1,571,474
+22,883
+1% +$301K ﹤0.01% 2498
2019
Q1
$23.4M Buy
1,548,591
+124,844
+9% +$1.89M ﹤0.01% 2429
2018
Q4
$24.4M Buy
1,423,747
+48,038
+3% +$825K ﹤0.01% 2359
2018
Q3
$20.3M Buy
1,375,709
+113,038
+9% +$1.67M ﹤0.01% 2571
2018
Q2
$30.1M Buy
1,262,671
+152,508
+14% +$3.64M ﹤0.01% 2379
2018
Q1
$28.4M Buy
1,110,163
+65,655
+6% +$1.68M ﹤0.01% 2356
2017
Q4
$19.3M Buy
1,044,508
+136,562
+15% +$2.52M ﹤0.01% 2501
2017
Q3
$9.53M Buy
907,946
+119,689
+15% +$1.26M ﹤0.01% 2833
2017
Q2
$9.86M Sell
788,257
-18,282
-2% -$229K ﹤0.01% 2779
2017
Q1
$8.11M Buy
806,539
+58,398
+8% +$587K ﹤0.01% 2849
2016
Q4
$11.6M Buy
748,141
+225,553
+43% +$3.51M ﹤0.01% 2678
2016
Q3
$10.1M Buy
522,588
+36,779
+8% +$708K ﹤0.01% 2681
2016
Q2
$5.76M Buy
485,809
+36,987
+8% +$438K ﹤0.01% 2910
2016
Q1
$8.15M Buy
448,822
+200,501
+81% +$3.64M ﹤0.01% 2721
2015
Q4
$6.83M Buy
248,321
+61,429
+33% +$1.69M ﹤0.01% 2835
2015
Q3
$4.13M Buy
186,892
+105,274
+129% +$2.33M ﹤0.01% 3059
2015
Q2
$1.46M Buy
+81,618
New +$1.46M ﹤0.01% 3547